Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
VATE Stock Forecast 2025-2026
$4.95
Current Price
$67.59M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to VATE Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
VATE Price Momentum
-1.0%
1 Week Change
-12.9%
1 Month Change
-22.2%
1 Year Change
+0.2%
Year-to-Date Change
-64.1%
From 52W High of $13.79
+22.2%
From 52W Low of $4.05
📊 TOP ANALYST CALLS
Did VATE Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Elev8 Brands is one of their latest high-conviction picks.
Latest VATE Stock Price Targets & Analyst Predictions
VATE has shown a year-to-date change of 0.2% and a 1-year change of -22.2%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for VATE. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
VATE Analyst Ratings
0
Buy
0
Hold
0
Sell
VATE Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $4.95
Latest VATE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for VATE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Innovate Corp. (VATE) Competitors
The following stocks are similar to Elev8 Brands based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Innovate Corp. (VATE) Financial Data
Innovate Corp. has a market capitalization of $67.59M with a P/E ratio of -1.6x. The company generates $1.10B in trailing twelve-month revenue with a -6.3% profit margin.
Revenue growth is +43.3% quarter-over-quarter, while maintaining an operating margin of +1.8% and return on equity of +22.4%.
Valuation Metrics
Market Cap
$67.59M
Enterprise Value
$780.98M
P/E Ratio
-1.6x
PEG Ratio
0.0x
Price/Sales
0.1x
Growth & Margins
Revenue Growth (YoY)
+43.3%
Gross Margin
+14.3%
Operating Margin
+1.8%
Net Margin
-6.3%
EPS Growth
+43.3%
Financial Health
Cash/Price Ratio
+52.5%
Current Ratio
0.4x
Debt/Equity
-3.3x
ROE
+22.4%
ROA
+1.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Innovate Corp. (VATE) Business Model
About Innovate Corp.
What They Do
A diversified holding company in industrial and financial services.
Business Model
Innovate Corp. generates revenue by acquiring and managing subsidiary companies across various industries, focusing on operational efficiencies and strategic growth. It operates in sectors such as engineering, construction, and maintenance, while also providing financial services like insurance and asset management to both business and individual clients.
Additional Information
The company aims to create synergies between its diverse operations and leverage industry expertise for value creation. By pursuing strategic acquisitions and innovative management practices, Innovate Corp. seeks to capitalize on emerging market trends, positioning itself as a key player in both industrial growth and financial solutions.
Company Information
Sector
Industrials
Industry
Engineering & Construction
Employees
3,135
CEO
Country
United States
IPO Year
2021
Website
www.innovatecorp.comInnovate Corp. (VATE) Latest News & Analysis
Latest News
Quick Summary
INNOVATE Corp. (VATE) will hold its Q3 2025 earnings call on November 12, 2025, at 4:30 PM EST, featuring CEO Neel Sikka and CFO Michael Sena.
Why It Matters
The Q3 2025 earnings call for INNOVATE Corp. will provide crucial insights into financial performance, strategic direction, and management outlook, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
DBM Global reports strong revenue growth; MediBeacon gains regulatory approval for its Transdermal GFR System in China; Spectrum sees early recovery in Q4 advertising sales.
Why It Matters
Robust revenue growth from DBM Global signals market strength, while MediBeacon's regulatory approval opens new revenue opportunities. Spectrum's ad sales recovery suggests improving market conditions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
INNOVATE Corp. (NYSE: VATE) will release Q3 2025 financial results on November 12, 2025, after market close, with a conference call at 4:30 p.m. ET the same day.
Why It Matters
The upcoming financial results and conference call for INNOVATE Corp. on November 12 may influence stock performance and investor sentiment, providing insights into the company's operations and strategy.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
INNOVATE Corp. (NYSE: VATE) announced that its investment, MediBeacon Inc., received NMPA approval for Lumitrace® injection, a non-radioactive GFR agent, to be sold in China.
Why It Matters
Approval of Lumitrace® enhances MediBeacon's market position in China, potentially increasing revenues and benefiting INNOVATE Corp.'s investment, positively influencing its stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
INNOVATE Corp. (NYSE: VATE) announced that its subsidiary DBM Global Inc. will pay a cash dividend of $8.8 million on November 10, 2025, with INNOVATE set to receive approximately $8 million.
Why It Matters
DBMG's $8.8 million dividend reflects strong performance, benefiting INNOVATE's financials with an $8 million payout. This could enhance INNOVATE's stock value and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
INNOVATE Corp. (NYSE: VATE) reported a Q2 2025 revenue increase of 88% for its subsidiary R2 Technologies, driven by the Glacial® Skin technology, indicating strong growth in the global aesthetics market.
Why It Matters
The 88% revenue increase for R2 Technologies highlights strong growth potential in the aesthetics sector, signaling possible future gains for INNOVATE Corp. and increased investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About VATE Stock
What is Innovate Corp.'s (VATE) stock forecast for 2026?
Analyst forecasts for Innovate Corp. (VATE) are not currently available. The stock is trading at $4.95.
Is VATE stock a good investment in 2026?
Analyst ratings for VATE are not currently available. The stock is currently trading at $4.95. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for VATE stock?
Price predictions from Wall Street analysts for VATE are not currently available. The stock is trading at $4.95.
What is Innovate Corp.'s business model?
Innovate Corp. generates revenue by acquiring and managing subsidiary companies across various industries, focusing on operational efficiencies and strategic growth. It operates in sectors such as engineering, construction, and maintenance, while also providing financial services like insurance and asset management to both business and individual clients.
What is the highest forecasted price for VATE Innovate Corp.?
Price targets from Wall Street analysts for VATE are not currently available. The stock is trading at $4.95.
What is the lowest forecasted price for VATE Innovate Corp.?
Price targets from Wall Street analysts for VATE are not currently available. The stock is trading at $4.95.
What is the overall VATE consensus from analysts for Innovate Corp.?
Analyst ratings for VATE are not currently available. The stock is trading at $4.95.
How accurate are VATE stock price projections?
Stock price projections, including those for Innovate Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 9, 2025 10:04 AM UTC